Liran Zhou

437 total citations
10 papers, 324 citations indexed

About

Liran Zhou is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Liran Zhou has authored 10 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Genetics. Recurrent topics in Liran Zhou's work include Prostate Cancer Treatment and Research (3 papers), Cell death mechanisms and regulation (2 papers) and RNA Interference and Gene Delivery (2 papers). Liran Zhou is often cited by papers focused on Prostate Cancer Treatment and Research (3 papers), Cell death mechanisms and regulation (2 papers) and RNA Interference and Gene Delivery (2 papers). Liran Zhou collaborates with scholars based in United States, Germany and United Kingdom. Liran Zhou's co-authors include Zhengxin Wang, Shen Gao, Marina Konopleva, Michael Andreeff, Vivian Ruvolo, Defeng Deng, Craig D. Logsdon, Todd T. Moore, Rosa F. Hwang and Huamin Wang and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Liran Zhou

10 papers receiving 322 citations

Peers

Liran Zhou

MB

ONCOL

CR

PRM

IMMUN

Mara Mazzoni Italy

Areumnuri Kim South Korea

Michael W. Potter United States

Ana Rita Lourenço Netherlands

Lorenza Maltese Italy

Astrid Grottke Germany

Chun‐Hua Wang China

Dimuthu Perera United States

Zhenqian Wu China

Kati Servan Germany

Mara Mazzoni Italy

Liran Zhou

196 ×0.9

MB

117 ×1.2

ONCOL

58 ×0.8

CR

59 ×0.9

PRM

62 ×1.4

IMMUN

Citations per year, relative to Liran Zhou Liran Zhou (= 1×) peers Mara Mazzoni

Countries citing papers authored by Liran Zhou

Since Specialization

Citations

This map shows the geographic impact of Liran Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liran Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liran Zhou more than expected).

Fields of papers citing papers by Liran Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liran Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liran Zhou. The network helps show where Liran Zhou may publish in the future.

Co-authorship network of co-authors of Liran Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Liran Zhou. A scholar is included among the top collaborators of Liran Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liran Zhou. Liran Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Zhou, Liran, Todd T. Moore, Mason Lu, et al.. (2018). Suppression of stromal-derived Dickkopf-3 (DKK3) inhibits tumor progression and prolongs survival in pancreatic ductal adenocarcinoma. Science Translational Medicine. 10(464). 31 indexed citations

2.

Świdnicka‐Siergiejko, Agnieszka, Myrriah Chavez-Tomar, Gregory B. Lesinski, et al.. (2017). Lipocalin-2 Promotes Pancreatic Ductal Adenocarcinoma by Regulating Inflammation in the Tumor Microenvironment. Cancer Research. 77(10). 2647–2660. 114 indexed citations

3.

Zhang, Weiguo, Vivian Ruvolo, Gao Chen, et al.. (2014). Evaluation of Apoptosis Induction by Concomitant Inhibition of MEK, mTOR, and Bcl-2 in Human Acute Myelogenous Leukemia Cells. Molecular Cancer Therapeutics. 13(7). 1848–1859. 30 indexed citations

4.

Ruvolo, Peter P., Vivian Ruvolo, Rodrigo Jácamo, et al.. (2014). The protein phosphatase 2A regulatory subunit B55α is a modulator of signaling and microRNA expression in acute myeloid leukemia cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1843(9). 1969–1977. 30 indexed citations

5.

Zhou, Liran, et al.. (2013). cGMP-Dependent Protein Kinase Iβ Interacts with p44/WDR77 to Regulate Androgen Receptor-Driven Gene Expression. PLoS ONE. 8(6). e63119–e63119. 7 indexed citations

6.

Gu, Zhongping, Liran Zhou, Shen Gao, & Zhengxin Wang. (2011). Nuclear Transport Signals Control Cellular Localization and Function of Androgen Receptor Cofactor p44/WDR77. PLoS ONE. 6(7). e22395–e22395. 19 indexed citations

7.

Ruvolo, Peter P., Liran Zhou, Julie C. Watt, et al.. (2011). Targeting PKC‐mediated signal transduction pathways using enzastaurin to promote apoptosis in acute myeloid leukemia‐derived cell lines and blast cells. Journal of Cellular Biochemistry. 112(6). 1696–1707. 29 indexed citations

8.

Wei, Qi, Shen Gao, Jun Chu, Liran Zhou, & Zhengxin Wang. (2011). Negative Androgen‐Response Elements Mediate Androgen‐Dependent Transcriptional Inhibition of TGF‐β1 and CDK2 Promoters in the Prostate Gland. Journal of Andrology. 33(1). 27–36. 13 indexed citations

9.

Zhou, Liran, Marina Konopleva, & Michael Andreeff. (2008). HDAC Inhibition by SNDX-275 (Entinostat) Restores Expression of Silenced Leukemia-Associated Transcription Factors Nur77 and Nor1 and of Key Pro-Apoptotic Proteins in AML. Blood. 112(11). 311–311. 2 indexed citations

10.

Gao, Shen, Hua Wang, Peng Lee, et al.. (2006). Androgen receptor and prostate apoptosis response factor-4 target the c-FLIP gene to determine survival and apoptosis in the prostate gland. Journal of Molecular Endocrinology. 36(3). 463–483. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact